Chronic Kidney Disease Trial, Recruiting NCT06754280 Sponsor: University of Illinois at Chicago Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06754280
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as Black or African American
  • People between the ages of 35 and 80 years old
  • People who have been diagnosed with chronic kidney disease (CKD) at stage 1, 2, 3, or 4
  • People who report spending 6 or more hours per day sitting or being inactive
  • People who can speak, read, and understand English
  • People who have access to a telephone

Who may not be able to join:

  • People who are unable to walk the distance of one city block
  • People who cannot stand up from a seated position on their own, without help from another person or device
  • People who rely on a wheelchair, walker, or cane for all of their movement
  • People who have had a lower leg or upper leg amputation and do not use a prosthetic limb
  • People who have a bone or joint condition that would prevent them from sitting down and standing up repeatedly, or from standing (confirm with trial site)
  • People who have a neurological or psychiatric condition that would prevent them from sitting down and standing up repeatedly, or from standing (confirm with trial site)
  • People who have severe cognitive impairment (serious difficulties with memory, thinking, or understanding)
  • People who have unstable heart disease, such as chest pain that occurs with physical activity
  • People who have a condition where their blood pressure drops significantly when they stand up (orthostatic hypotension)
  • People who have had a kidney transplant
  • People who have already taken part in the Patient Advisory Board for this study
  • People who have any other condition that the trial investigators determine would prevent safe participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 3123554838

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
13 March 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in sedentary time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov